| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1008947287 |
| P356 | DOI | 10.1186/2051-5960-1-3 |
| P932 | PMC publication ID | 3776211 |
| P698 | PubMed publication ID | 24252508 |
| P5875 | ResearchGate publication ID | 257103989 |
| P50 | author | Sharon C Yates | Q59694396 |
| P2093 | author name string | Zsuzsanna Nagy | |
| A David Smith | |||
| Margaret M Esiri | |||
| Roy Bicknell | |||
| Paul Hubbard | |||
| Gordon Wilcock | |||
| Sharon Christie | |||
| Sarah Durant | |||
| Amen Zafar | |||
| Sheila Nagy | |||
| P2860 | cites work | Control of dendritic arborization by the phosphoinositide-3'-kinase-Akt-mammalian target of rapamycin pathway. | Q46843629 |
| Quality control for microarray analysis of human brain samples: The impact of postmortem factors, RNA characteristics, and histopathology | Q48106242 | ||
| Rapamycin is a neuroprotective treatment for traumatic brain injury. | Q48290046 | ||
| The cell division cycle and the pathophysiology of Alzheimer's disease | Q48382381 | ||
| Genome wide profiling of altered gene expression in the neocortex of Alzheimer's disease | Q48398994 | ||
| Activated mTOR and PKR kinases in lymphocytes correlate with memory and cognitive decline in Alzheimer's disease | Q48428585 | ||
| Differences in apolipoprotein E3/3 and E4/4 allele-specific gene expression in hippocampus in Alzheimer disease | Q48751082 | ||
| P53-mediated G(1)/S checkpoint dysfunction in lymphocytes from Alzheimer's disease patients. | Q53305818 | ||
| Phosphorylated eukaryotic translation factor 4E is elevated in Alzheimer brain. | Q53366814 | ||
| MCI is a clinically useful concept. | Q53380350 | ||
| Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease | Q21136406 | ||
| Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments | Q24633947 | ||
| Cluster analysis and display of genome-wide expression patterns | Q24644463 | ||
| mTOR signaling: at the crossroads of plasticity, memory and disease | Q24647655 | ||
| Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease | Q24685592 | ||
| The genetics of Alzheimer disease | Q27026166 | ||
| Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease | Q27860795 | ||
| Levels of mTOR and its downstream targets 4E-BP1, eEF2, and eEF2 kinase in relationships with tau in Alzheimer's disease brain | Q28267027 | ||
| mTOR-dependent signalling in Alzheimer's disease | Q28308319 | ||
| Alterations in mammalian target of rapamycin signaling pathways after traumatic brain injury | Q28571240 | ||
| The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy | Q28579751 | ||
| Molecular mechanisms of mTOR-mediated translational control | Q29615529 | ||
| A SAGE study of apolipoprotein E3/3, E3/4 and E4/4 allele-specific gene expression in hippocampus in Alzheimer disease | Q33297839 | ||
| Impact of RNA degradation on gene expression profiling. | Q33652966 | ||
| Dysregulation of the mTOR pathway mediates impairment of synaptic plasticity in a mouse model of Alzheimer's disease | Q33700331 | ||
| Developing Antiepileptogenic Drugs for Acquired Epilepsy: Targeting the Mammalian Target of Rapamycin (mTOR) Pathway | Q33805859 | ||
| Alzheimer's disease as a disorder of mechanisms underlying structural brain self-organization | Q34142269 | ||
| Gene expression reveals overlap between normal aging and Alzheimer's disease genes | Q34154632 | ||
| Synaptic plasticity and cell cycle activation in neurons are alternative effector pathways: the 'Dr. Jekyll and Mr. Hyde concept' of Alzheimer's disease or the yin and yang of neuroplasticity | Q35612500 | ||
| Alzheimer's disease and the amyloid cascade hypothesis: a critical review | Q35855587 | ||
| The last neuronal division: a unifying hypothesis for the pathogenesis of Alzheimer's disease. | Q36275654 | ||
| Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses | Q36605276 | ||
| Linking cell-cycle dysfunction in Alzheimer's disease to a failure of synaptic plasticity | Q36712611 | ||
| Role of mTOR in physiology and pathology of the nervous system | Q36959417 | ||
| Regulation of cell death and epileptogenesis by the mammalian target of rapamycin (mTOR): a double-edged sword? | Q37603072 | ||
| Mammalian target of rapamycin: discovery of rapamycin reveals a signaling pathway important for normal and cancer cell growth | Q37645017 | ||
| Neuroimaging results impose new views on Alzheimer's disease--the role of amyloid revised | Q37971458 | ||
| Microarray gene expression analysis of fixed archival tissue permits molecular classification and identification of potential therapeutic targets in diffuse large B-cell lymphoma. | Q38404561 | ||
| Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer's disease | Q38504815 | ||
| The immunosuppressant rapamycin exacerbates neurotoxicity of Abeta peptide | Q40235082 | ||
| P70 S6 kinase mediates tau phosphorylation and synthesis | Q40338655 | ||
| Staging of Alzheimer's disease-related neurofibrillary changes | Q40416705 | ||
| Rapamycin blocks IL-2-driven T cell cycle progression while preserving T cell survival | Q40805846 | ||
| Cell cycle kinesis in lymphocytes in the diagnosis of Alzheimer's disease | Q43832582 | ||
| P921 | main subject | Alzheimer's disease | Q11081 |
| risk factor | Q1475848 | ||
| P304 | page(s) | 3 | |
| P577 | publication date | 2013-05-08 | |
| P1433 | published in | Acta Neuropathologica Communications | Q27724912 |
| P1476 | title | Dysfunction of the mTOR pathway is a risk factor for Alzheimer's disease | |
| P478 | volume | 1 |
| Q46778500 | Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD. |
| Q36539459 | Analysis of Proteins That Rapidly Change Upon Mechanistic/Mammalian Target of Rapamycin Complex 1 (mTORC1) Repression Identifies Parkinson Protein 7 (PARK7) as a Novel Protein Aberrantly Expressed in Tuberous Sclerosis Complex (TSC) |
| Q48547364 | AβPP/PS1 Transgenic Mice Show Sex Differences in the Cerebellum Associated with Aging |
| Q37662094 | Consumption of pomegranates improves synaptic function in a transgenic mice model of Alzheimer's disease |
| Q54113689 | Could Alzheimer's Disease Originate in the Periphery and If So How So? |
| Q40143766 | Deletion of mTOR in Reactive Astrocytes Suppresses Chronic Seizures in a Mouse Model of Temporal Lobe Epilepsy |
| Q36690758 | Dysregulation of Nutrient Sensing and CLEARance in Presenilin Deficiency. |
| Q38180394 | Inflammation and programmed cell death in Alzheimer's disease: comparison of the central nervous system and peripheral blood. |
| Q41367811 | Luteolin, a natural flavonoid, inhibits methylglyoxal induced apoptosis via the mTOR/4E-BP1 signaling pathway |
| Q38367422 | Oxidative Stress and Aberrant Cell Cycle in Alzheimer's Disease Lymphocytes: Diagnostic Prospects |
| Q64103320 | Physical Activity Alleviates Cognitive Dysfunction of Alzheimer's Disease through Regulating the mTOR Signaling Pathway |
| Q28277112 | Pim1 inhibition as a novel therapeutic strategy for Alzheimer's disease |
| Q42397376 | Preparing for an Aging World: Engaging Biogerontologists, Geriatricians, and the Society |
| Q38200151 | Signaling pathway cross talk in Alzheimer's disease |
| Q38815881 | Targeting mTOR to reduce Alzheimer-related cognitive decline: from current hits to future therapies |
| Q59808453 | The Early Events That Initiate β-Amyloid Aggregation in Alzheimer's Disease |
| Q48201452 | The Interplay Between Apolipoprotein E4 and the Autophagic-Endocytic-Lysosomal Axis. |
| Q89544479 | The emerging roles of protein homeostasis-governing pathways in Alzheimer's disease |
| Q51737088 | Update on Vascular Cognitive Impairment Associated with Subcortical Small-Vessel Disease. |
Search more.